Satellos Bioscience (STU:0IT) Net Change in Cash : €23.68 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Satellos Bioscience's Net Change in Cash for the three months ended in Dec. 2024 was €22.95 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was €23.68 Mil.

Satellos Bioscience Net Change in Cash Historical Data

The historical data trend for Satellos Bioscience's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Net Change in Cash Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

0.20

2.87

-2.15

13.77

23.86

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial													-15.17	-6.09	-2.23	9.04	22.95

Satellos Bioscience Net Change in Cash Calculation

Satellos Bioscience's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-16.741	+	4.248	+	35.852	+	0.499
	=	23.86

Satellos Bioscience's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -5.234 + -7.789 + 35.693 + 0.28

= 22.95

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satellos Bioscience Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Satellos Bioscience's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (STU:0IT) » Definitions » Net Change in Cash

Comparable Companies

TSXV:ARCH TSX:MDNA XCNQ:GLAB TSX:ONC TSXV:COV XCNQ:ONCO TSXV:MIR TSX:SVA TSXV:NRX TSXV:SHRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270

Traded in Other Exchanges

MSCLF:USA 0ITA:Germany MSCL:Canada

Address

200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience Headlines

No Headlines